Fetomaternal outcome in patients with placenta previa

Wasim, Tayyiba; Bushra, Natasha; Riaz, Saher; Iqbal, Hafiza Iqra

doi:10.12669/pjms.36.5.1647

Cited by 17 publications

(30 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Wasim et al [16] stated that fetal outcome was good in patients with MAP and placenta previa in our study with majority (73.2% vs 65.6%) delivering after 36 weeks with good APGAR and babies having birth weight ≥2.5kg and only three neonatal deaths due to prematurity.…”

Section: Fetal Outcomesupporting

confidence: 45%

See 1 more Smart Citation

To study the maternal and perinatal outcomes in patients suffering from placenta previa

Maheshwari¹,

Pandey²,

Singhal³

2021

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

Background: Placenta previa is a disorder which occurs during pregnancy that is characterized by the presence of placental tissue close to or covering the cervix increasing the risk of antepartum, intrapartum and postpartum hemorrhage. Rapid significant loss of intravascular volume can lead to hemodynamic instability, decreased oxygen delivery, decreased tissue perfusion, cellular hypoxia, organ damage and death. Infants born to such patients are also at risk of premature deliveries and increased perinatal mortality. Method: This prospective randomized clinical study was conducted in the Department of Obstetrics & Gynecology, Muzaffarnagar Medical College, Muzaffarnagar, Uttar Pradesh the period 2018-2020 after considering the inclusion and exclusion criterias. Result: Primigravida were more affected than multigravia. Majority patients underwent Emergency LSCS than Elective one. PPH, Pre-operative and Post-operative anaemia and Adherent placenta was significantly more among Emergency LSCS. NICU admission was significantly more among Emergency LSCS. Conclusion:The current study suggested that there is an association between advancing age, previous caesarean section and abortion as the risk factors for placenta previa. Placenta previa as noted from the study was seen to be associated with increased risk of maternal complications like PPH and neonatal complications including prematurity and low birth weight.

show abstract

Section: Fetal Outcomesupporting

confidence: 45%

“…It was significantly more among subjects with Emergency LSCS, APGAR score, NICU admission and duration of hospital stay > 10 days. Wasim et al [16] reported that low case fatality of 3% as only two patients died.…”

Section: Mortalitymentioning

confidence: 98%

To study the maternal and perinatal outcomes in patients suffering from placenta previa

Maheshwari¹,

Pandey²,

Singhal³

2021

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

show abstract

“…The placenta previa (PP) is defined as placenta complete or partial covering the internal orifice of cervix (1), the prevalence of PP in obstetrics is about 0.3-1.5% (2). The PP is a major risk factor for severe postpartum hemorrhage (SPPH), which is the leading cause of maternal and neonate mortality and morbidity worldwide (3,4).…”

Section: Introductionmentioning

confidence: 99%

Developing and Validating Nomogram to Predict Severe Postpartum Hemorrhage in Women With Placenta Previa Undergoing Cesarean Delivery: A Multicenter Retrospective Case-Control Study

et al. 2022

View full text Add to dashboard Cite

ObjectiveDeveloping and validating nomogram to predict severe postpartum hemorrhage (SPPH) in women with placenta previa (PP) undergoing cesarean delivery.MethodsWe conducted a multicenter retrospective case-control study in five hospitals. In this study, 865 patients from January, 2018 to June, 2020 were enrolled in the development cohort, and 307 patients from July, 2020 to June, 2021 were enrolled in the validation cohort. Independent risk factors for SPPH were obtained by using the multivariate logistic regression, and preoperative nomogram and intraoperative nomogram were developed, respectively. We compared the discrimination, calibration, and net benefit of the two nomograms in the development cohort and validation cohort. Then, we tested whether the intraoperative nomogram could be used before operation.ResultsThere were 204 patients (23.58%) in development cohort and 80 patients (26.06%) in validation cohort experienced SPPH. In development cohort, the areas under the receiver operating characteristic (ROC) curve (AUC) of the preoperative nomogram and intraoperative nomogram were 0.831 (95% CI, 0.804, 0.855) and 0.880 (95% CI, 0.854, 0.905), respectively. In validation cohort, the AUC of the preoperative nomogram and intraoperative nomogram were 0.825 (95% CI, 0.772, 0.877) and 0.853 (95% CI, 0.808, 0.898), respectively. In the validation cohort, the AUC was 0.839 (95% CI, 0.789, 0.888) when the intraoperative nomogram was used before operation.ConclusionWe developed the preoperative nomogram and intraoperative nomogram to predict the risk of SPPH in women with PP undergoing cesarean delivery. By comparing the discrimination, calibration, and net benefit of the two nomograms in the development cohort and validation cohort, we think that the intraoperative nomogram performed better. Moreover, application of the intraoperative nomogram before operation can still achieve good prediction effect, which can be improved if the severity of placenta accreta spectrum (PAS) can be accurately distinguished preoperatively. We expect to conduct further prospective external validation studies on the intraoperative nomogram to evaluate its application value.

show abstract

“…According to the literature, the incidence of PP shows an increasing trend year by year with the increase of cesarean section rate, abortion rate, and uterine operations ( 2 – 4 ). The presence of PP can increase the risk of maternal hemorrhage in late pregnancy, during labor, and in the postpartum period, and in severe cases can lead to hemodynamic instability, reduced oxygen supply, and organ damage causing emergency unscheduled surgery requiring massive blood transfusion; it can also produce serious symptoms such as disseminated intravascular coagulation and multiple organ dysfunction syndrome, which are the main causes of maternal and perinatal death ( 5 , 6 ).…”

Section: Prefacementioning

confidence: 99%

Clinical Analysis of Factors Influencing the Development of Placenta Praevia and Perinatal Outcomes in First-Time Pregnant Patients

Zhou

Zhao

2022

Front. Surg.

View full text Add to dashboard Cite

ObjectiveTo analyze the risk factors associated with the development of placenta praevia (PP) in first-time pregnant patients and to observe the perinatal clinical outcomes of patients.MethodsThe clinical data of 112 pregnant women with PP (PP group) and 224 pregnant women with normal placental position (general group) who delivered in our hospital from August 2016 to August 2021 were retrospectively analyzed. Baseline demographic data such as age, gestational week, uterine history, assisted reproductive technology use, pregnancy comorbidities, pre-pregnancy body mass index (BMI), smoking, alcohol consumption, placental position, educational level, work were collected from both groups, and logistic regression models were used to analyze the factors influencing the occurrence of PP in patients with first pregnancy. Perinatal outcomes such as implementation of hemostatic treatment (uterine balloon compression, arterial ligation, and B-Lynch suture), maternal postpartum related indicators (amount of postpartum bleeding, incidence of postpartum hemorrhage, blood transfusion rate, blood transfusion volume, and length of hospital stay), and neonatal condition (birth weight, Apgar score at 1 and 5 min after birth) were counted and compared between the two groups.ResultsHistories of endometriosis, use of assisted reproductive technology, and smoking or secondhand smoke inhalation were all high risk factors for PP in patients with first pregnancies, and the proportion of maternal and neonatal adverse outcomes was significantly higher in the PP group than in the general group (P < 0.05).ConclusionHistories of endometriosis, smoking (secondhand smoke), and use of assisted reproductive technologies are independent risk factors for PP in patients with first pregnancies, which can increase the risk of labor and death of the newborn.

show abstract

Fetomaternal outcome in patients with placenta previa

Cited by 17 publications

References 18 publications

To study the maternal and perinatal outcomes in patients suffering from placenta previa

To study the maternal and perinatal outcomes in patients suffering from placenta previa

Developing and Validating Nomogram to Predict Severe Postpartum Hemorrhage in Women With Placenta Previa Undergoing Cesarean Delivery: A Multicenter Retrospective Case-Control Study

Clinical Analysis of Factors Influencing the Development of Placenta Praevia and Perinatal Outcomes in First-Time Pregnant Patients

Contact Info

Product

Resources

About